RELATED CONTENT
News | Neuro Imaging
Jan Medical announced today that it has secured $7.5 million in Series C funding from Brainlab Inc. Funds will be used to complete ongoing clinical trials and filing of product de novo with the U.S. Food and Drug Administration (FDA) and CE Mark registration in the EU for BrainPulse, a new diagnostic tool designed to rapidly and reliably help detect abnormal neurological conditions including concussion and stroke.
January 25, 2016 
News
Jan Medical and Brainlab announced a collaboration and Series B funding efforts to complete two clinical trials and the subsequent filing of two product 510(k)s with the U.S. Food and Drug Administration (FDA). Brainlab will also add a member representative to the Jan Medical Board of Directors.
September 27, 2013 